Gray Pearson - Publications

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Jaykumar AB, Jung JU, Parida PK, Dang TT, Wichaidit C, Kannangara AR, Earnest S, Goldsmith EJ, Pearson GW, Malladi S, Cobb MH. WNK1 Enhances Migration and Invasion in Breast Cancer Models. Molecular Cancer Therapeutics. PMID 34253593 DOI: 10.1158/1535-7163.MCT-21-0174  0.495
2021 Sharif GM, Campbell MJ, Nasir A, Sengupta S, Graham GT, Kushner MH, Kietzman WB, Schmidt MO, Pearson GW, Loudig O, Fineberg S, Wellstein A, Riegel AT. An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer. Cancer Research. PMID 34135000 DOI: 10.1158/0008-5472.CAN-20-3625  0.313
2016 Dang TT, Westcott JM, Maine EA, Kanchwala M, Xing C, Pearson GW. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion. Oncotarget. PMID 27081041 DOI: 10.18632/oncotarget.8696  0.302
2016 Maine EA, Westcott JW, Prechtl AM, Dang TT, Whitehurst AW, Pearson GW. The cancer/testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion. Oncotarget. PMID 26895102 DOI: 10.18632/oncotarget.7408  0.574
2015 Dang TT, Esparza MA, Maine EA, Westcott JM, Pearson GW. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program. Cancer Research. 75: 3925-35. PMID 26292362 DOI: 10.1158/0008-5472.CAN-14-3363  0.317
2014 Dbouk HA, Weil LM, Perera GK, Dellinger MT, Pearson G, Brekken RA, Cobb MH. Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK. Proceedings of the National Academy of Sciences of the United States of America. 111: 15999-6004. PMID 25362046 DOI: 10.1073/Pnas.1419057111  0.538
2014 Prechtl A, Westcott J, Dang T, Maine E, Pearson G. Abstract 3161: Non-cell autonomous regulation of collective invasion be an epigenetically distinct subpopulation of tumor cells Cancer Research. 74: 3161-3161. DOI: 10.1158/1538-7445.Am2014-3161  0.369
2013 Pearson G, Prechtl A, Westcott J, Dang T, Maine E. Abstract 4930: A commensal relationship between tumor cell subpopulations promotes collective invasion. Cancer Research. 73: 4930-4930. DOI: 10.1158/1538-7445.Am2013-4930  0.36
2009 Pearson GW, Hunter T. PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture. Breast Cancer Research : Bcr. 11: R29. PMID 19457236 DOI: 10.1186/Bcr2259  0.428
2007 Pearson GW, Hunter T. Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. The Journal of Cell Biology. 179: 1555-67. PMID 18166657 DOI: 10.1083/Jcb.200706099  0.559
2006 Ranganathan A, Pearson GW, Chrestensen CA, Sturgill TW, Cobb MH. The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Archives of Biochemistry and Biophysics. 449: 8-16. PMID 16626623 DOI: 10.1016/J.Abb.2006.02.023  0.604
2006 Pearson GW, Earnest S, Cobb MH. Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. Molecular and Cellular Biology. 26: 3039-47. PMID 16581779 DOI: 10.1128/MCB.26.8.3039-3047.2006  0.614
2002 Pearson GW, Cobb MH. Cell condition-dependent regulation of ERK5 by cAMP. The Journal of Biological Chemistry. 277: 48094-8. PMID 12297510 DOI: 10.1074/jbc.M208535200  0.613
2001 Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH. MAP kinases. Chemical Reviews. 101: 2449-76. PMID 11749383 DOI: 10.1021/cr000241p  0.52
2001 Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. The Embo Journal. 20: 2757-67. PMID 11387209 DOI: 10.1093/Emboj/20.11.2757  0.341
2001 Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews. 22: 153-83. PMID 11294822 DOI: 10.1210/Edrv.22.2.0428  0.59
2001 Pearson G, English JM, White MA, Cobb MH. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. The Journal of Biological Chemistry. 276: 7927-31. PMID 11118448 DOI: 10.1074/Jbc.M009764200  0.603
2000 Pearson G, Bumeister R, Henry DO, Cobb MH, White MA. Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. The Journal of Biological Chemistry. 275: 37303-6. PMID 11018021 DOI: 10.1074/Jbc.C000570200  0.636
1999 English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, Cobb MH. New insights into the control of MAP kinase pathways. Experimental Cell Research. 253: 255-70. PMID 10579927 DOI: 10.1006/Excr.1999.4687  0.563
1999 English JM, Pearson G, Hockenberry T, Shivakumar L, White MA, Cobb MH. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. The Journal of Biological Chemistry. 274: 31588-92. PMID 10531364 DOI: 10.1074/jbc.274.44.31588  0.566
1998 English JM, Pearson G, Baer R, Cobb MH. Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. The Journal of Biological Chemistry. 273: 3854-60. PMID 9461566 DOI: 10.1074/jbc.273.7.3854  0.579
Show low-probability matches.